Retrospective Evaluation of the Analgesic Effects of Molecular Target Agents Against Cancer Pain and Oxaliplatin-Induced Chronic Peripheral Neuropathy. Journal of Analytical Oncology, [S. l.], v. 11, p. 40–44, 2022. DOI: 10.30683/1927-7229.2022.11.06. Disponível em: https://neoplasiaresearch.com/index.php/jao/article/view/682. Acesso em: 18 apr. 2026.